Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Change in Receivables (2016 - 2024)

Bruker (BRKR) has disclosed Change in Receivables for 15 consecutive years, with $51.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Change in Receivables rose 546.09% year-over-year to $51.3 million, compared with a TTM value of $40.6 million through Dec 2024, up 4411.11%, and an annual FY2025 reading of -$54.2 million, down 233.5% over the prior year.
  • Change in Receivables was $51.3 million for Q4 2024 at Bruker, up from $18.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $51.3 million in Q4 2024 and bottomed at -$29.5 million in Q1 2020.
  • Average Change in Receivables over 5 years is $8.2 million, with a median of $600000.0 recorded in 2021.
  • The sharpest move saw Change in Receivables skyrocketed 1607.69% in 2021, then plummeted 1210.0% in 2023.
  • Year by year, Change in Receivables stood at -$3.9 million in 2020, then skyrocketed by 1320.51% to $47.6 million in 2021, then plummeted by 40.76% to $28.2 million in 2022, then crashed by 140.78% to -$11.5 million in 2023, then surged by 546.09% to $51.3 million in 2024.
  • Business Quant data shows Change in Receivables for BRKR at $51.3 million in Q4 2024, $18.8 million in Q3 2024, and -$13.9 million in Q2 2024.